Drug Combination Could Starve Pancreatic Cancer
NYU Langone experts leverage newfound combination of mechanisms to starve pancreatic tumors.
Drug Combo Overcomes Treatment Resistance in Blood Cancer
NYU Langone study shows that resistance of leukemia cells to venetoclax occurs because of a rapid increase in breakdown of mitochondria.
Drug Decriminalization Not Linked to More Overdose Deaths
NYU Langone study suggests there is no evidence of an association between drug decriminalization and fatal drug overdose rates.
Drug Effective for Metastatic Triple Negative Breast Cancer
NYU Langone study finds pembrolizumab is effective in shrinking tumors among metastatic triple negative breast cancer patients.
Drug May Prevent Bleeding in Malaria-Infected Brains
An NYU Langone study suggests that giving people with malaria a blood pressure drug may prevent brain hemorrhages and save lives.
Drug May Protect Ovaries & Fertility During Chemotherapy
NYU Langone study finds the drug everolimus keeps standard chemotherapy from depleting stores of cells needed for pregnancy in mice.
Drug Reduces Brain Damage Caused by Anesthesia
NYU Langone study finds an experimental drug prevented learning deficits caused by general anesthesia in a research model.
Drug Relieves Brain Sluggishness in Adults with ADHD
NYU Langone study shows that a drug known to stimulate brain activity reduces symptoms of sluggish cognitive tempo in adults with ADHD.
Drug Shows Promise for Metastatic Non-Small Cell Lung Cancer
Dr. Joshua K. Sabari, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, presented the results of a promising lung cancer drug.
Drug Shows Promise for Subset of Non-Small Cell Lung Cancer
NYU Langone medical oncologist Dr. Vamsidhar Velcheti discusses a promising treatment for people with a subset of non-small cell lung cancer.